Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plewa

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2014
Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activationKi Jeong Lee, Weiya Wang, Rupa Padaki, et al.
Cancer Research|July 12, 2011
STK33 kinase activity is nonessential in KRAS-dependent cancer cellsCarol Babij, Yihong Zhang, Robert J Kurzeja, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2014
Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activationKi Jeong Lee, Weiya Wang, Rupa Padaki, et al.
Cancer Research|July 12, 2011
STK33 kinase activity is nonessential in KRAS-dependent cancer cellsCarol Babij, Yihong Zhang, Robert J Kurzeja, et al.
Pageof 1